(Q44276629)

1 December 2017

Low dose cyclosporin A therapy in chronic posterior uveitis (English)

1 reference

1 December 2017

1 reference

1 reference

Towler HM

1

1 reference

1 December 2017

Cliffe AM

series ordinal

2

1 reference

1 December 2017

Whiting PH

series ordinal

3

1 reference

1 December 2017

Forrester JV

series ordinal

4

1 reference

1 December 2017

1 January 1989

1 reference

1 December 2017

1 reference

1 December 2017

3 ( Pt 3)

1 reference

1 December 2017

282-287

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.1989.39

1 December 2017

0 references

cites work

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

Retina S antigen-induced uveitis. The efficacy of cyclosporine and corticosteroids in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

Treatment of Mooren's ulcer with cyclosporin A: report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

Short term cyclosporin A treatment of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

Cyclosporin A in the treatment of severe Behçet's uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

Action and toxicity of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

Treatment of intraocular inflammatory disease with cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Modulation of experimental retinal vasculitis using dexamethasone, cyclosporin A, and prazosin

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Cyclosporin improves Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Treatment of severe Graves' ophthalmopathy with cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Prolonged survival of corneal allografts in rabbits treated with cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Side effects of systemic cyclosporine in patients not undergoing transplantation

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Signs and symptoms of uveitis. I. Anterior uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Standardization of vitreal inflammatory activity in intermediate and posterior uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Cyclosporin in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1989.39

7 January 2021

Identifiers

DOI

10.1038/EYE.1989.39

1 reference

Dimensions Publication ID

1 December 2017

0 references

1 reference